Abstract:
본 발명은 아미노다이하이드로퀴놀린 화합물 또는 이의 약학적으로 허용 가능한 염을 유효성분으로 함유하는 암 질환의 예방 또는 치료용 약학적 조성물에 관한 것이다. 본 발명에 따른 아미노다이하이드로퀴놀린 화합물 또는 이의 약학적으로 허용 가능한 염은 암 세포의 특정 세포주기 단계를 제어하고, 세포사멸을 유도함으로써 암 세포의 증식을 억제하는 효과가 우수하므로, 이를 유효성분으로 함유하는 조성물은 암 질환의 예방 또는 치료용 약학적 조성물로 유용하게 사용될 수 있다.
Abstract:
PURPOSE: A producing method of a garlic extract having enhanced content of ajoene is provided to reduce the production costs for the garlic extract, and to simplify producing processes. CONSTITUTION: A producing method of a garlic extract having enhanced content of ajoene comprises the following steps: settling crushed garlic at room temperature for 30 minutes-2 hours; adding ethyl acetate into the garlic, and extracting the garlic at 45-75 deg C for 0.5-10 hours to obtain a garlic ethyl acetate extract; and adding water into the ethyl acetate extract, and fractionating the mixture to obtain the ajoene strengthened garlic extract. [Reference numerals] (AA) Garlic; (BB) Crushing and settling at room temperature for an hour (step 1), and extracting using ethyl acetate(60 deg. C, 8 hours)(step 2); (CC) Ethyl acetate extract; (DD) Adding water, and fractionating; (EE) Garlic extract having enhanced content of ajoene
Abstract:
PURPOSE: A pharmaceutical composition containing thiourea-based compounds is provided to reduce NF-kappaB activity and edema and pain and to prevent and treat inflammatory diseases. CONSTITUTION: A pharmaceutical composition for preventing and treating inflammatory diseases contains thiourea-based compounds of chemical formula 1 or pharmaceutically acceptable salt thereof as an active ingredient. The inflammatory diseases include asthma, periodontitis, stomatitis, peritonitis, gastritis, lymphocytic enteritis, arthritis, rheumatoid arthritis, nephritis, hepatitis and degenerative disease. A health food composition for preventing and treating inflammatory diseases contains the compound of chemical formula 1 or pharmaceutically acceptable salt thereof as an active ingredient.
Abstract:
PURPOSE: A novel rhodanine derivative which activates PPAR gamma is provided to prevent or treat PPAR-mediated diseases. CONSTITUTION: A beta-rhodanine derivative is denoted by chemical formula 1. A pharmaceutical composition for preventing and treating PPAR gamma-mediated diseases contains beta-carboxyethyl-rhodanine derivative or pharmaceutically acceptable salt as an active ingredient. The PPAR gamma-mediated diseases are diabetes, hypertension, artery scleroma, cardiovascular disease or metabolic disorder.